These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32199889)

  • 41. COVID-19 and gastrointestinal symptoms: the dust has not settled yet.
    Parigi TL; Vespa E; Pugliese N; Danese S
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):877-878. PubMed ID: 32729732
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.
    Kansal NK
    J Am Acad Dermatol; 2020 Jun; 82(6):e213. PubMed ID: 32246966
    [No Abstract]   [Full Text] [Related]  

  • 43. [A gastrointestinal overview of COVID-19].
    Konturek PC
    MMW Fortschr Med; 2020 Apr; 162(8):59-60. PubMed ID: 32342369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel coronavirus(Covid19), Its renal manifestations, and complications.
    Jadali Z
    Urol J; 2020 Sep; 17(5):558-559. PubMed ID: 32920815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Could reperfusion pulmonary oedema explain worsening progress in COVID-19 pneumonia?
    Paksu MS; Kilic M
    Emerg Med J; 2020 Nov; 37(11):705-706. PubMed ID: 32988992
    [No Abstract]   [Full Text] [Related]  

  • 47. Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.
    Conforti C; Giuffrida R; Dianzani C; Di Meo N; Zalaudek I
    Dermatol Ther; 2020 Jul; 33(4):e13490. PubMed ID: 32358864
    [No Abstract]   [Full Text] [Related]  

  • 48. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Krittanawong C; Virk HUH; Narasimhan B; Wang Z; Narasimhan H; Zhang HJ; Sun T; Messerli FH
    Prog Cardiovasc Dis; 2020; 63(4):527-528. PubMed ID: 32389584
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemostasis profile in COVID-19 infection.
    Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
    Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
    [No Abstract]   [Full Text] [Related]  

  • 50. Stroke as a complication of Coronavirus disease 2019 (COVID-19).
    Marín-Medina DS; Orozco-Hernández JP; Martínez-Muñoz MA; Sánchez-Duque JA
    Infez Med; 2020 Sep; 28(3):456-458. PubMed ID: 32920585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"?
    Pradère B; Ploussard G; Catto JWF; Rouprêt M; Misrai V
    Eur Urol; 2020 Aug; 78(2):134-135. PubMed ID: 32284245
    [No Abstract]   [Full Text] [Related]  

  • 52. ECG: essential in care of patients with COVID-19.
    Lam K; McClelland S; Dallo MJ
    Med J Aust; 2020 Nov; 213(10):476-476.e1. PubMed ID: 33098111
    [No Abstract]   [Full Text] [Related]  

  • 53. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
    Mastrolonardo M; Romita P; Bonifazi E; Giuffrida R; Lotti T; Foti C; Bonamonte D
    Dermatol Ther; 2020 Jul; 33(4):e13617. PubMed ID: 32424886
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
    Bragazzi NL; Riccò M; Pacifico A; Malagoli P; Kridin K; Pigatto P; Damiani G
    Dermatol Ther; 2020 Jul; 33(4):e13508. PubMed ID: 32415727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
    Halpin DMG; Faner R; Sibila O; Badia JR; Agusti A
    Lancet Respir Med; 2020 May; 8(5):436-438. PubMed ID: 32251625
    [No Abstract]   [Full Text] [Related]  

  • 56. [Older patients with a psychiatric disorder and covid-19: four waves of health risks].
    Dols A; Rhebergen D
    Tijdschr Psychiatr; 2020; 62(6):433-436. PubMed ID: 32902837
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter to the Editor: Importance of metabolic health in the era of COVID-19.
    Rebelos E; Moriconi D; Virdis A; Taddei S; Foschi D; Nannipieri M
    Metabolism; 2020 Jul; 108():154247. PubMed ID: 32333939
    [No Abstract]   [Full Text] [Related]  

  • 58. SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?
    Bardasi G; Alvisi P
    Dig Liver Dis; 2020 Nov; 52(11):1244-1245. PubMed ID: 32703727
    [No Abstract]   [Full Text] [Related]  

  • 59. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
    Turi S; Nardelli P; Landoni G
    Ann Card Anaesth; 2020; 23(3):258-259. PubMed ID: 32687078
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter Regarding "Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)".
    Bradford T
    Fetal Pediatr Pathol; 2020 Aug; 39(4):360-362. PubMed ID: 32720537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.